Skip to content

68Ga-FAPI-04 PET/CT for Detection of Locoregional Lymph Node Metastases in Gynecologic Squamous Cell Carcinoma

Oct 2026 · Anticancer Research · Vol 46, pp. 6319 - 6329 · 0 citations · 21 references
Medicine

TL;DR

In this small cohort, gallium-68 fibroblast activation protein inhibitor PET/CT showed a higher observed specificity than contrast-enhanced CT for the detection of locoregional LN metastases in gynecologic SCC, with no false-negative cases observed.

Abstract

Background/Aim: Detection of locoregional lymph node (LN) metastases is a critical prognostic factor in gynecologic squamous cell carcinoma (SCC). Contrast-enhanced computed tomography (CT) is limited by insufficient specificity, potentially leading to overtreatment. We evaluated gallium-68 fibroblast activation protein inhibitor (68Ga-FAPI-04) positron-emission tomography (PET)/CT for the detection of locoregional LN metastases in this setting, using CT as comparator. Patients and Methods: In this retrospective single-center study, 68Ga-FAPI-04 PET/CT scans of 15 patients with gynecologic SCC (nine cervical, six vulvar carcinomas; mean age 56.3 years, range=38-86 years) were analyzed. PET/CT and CT were read independently by two blinded readers. Histopathology and/or clinical and radiological follow-up (12-18 months) served as the reference standard. Diagnostic performance was calculated on a patient-based level; maximum standardized uptake values (SUVmax) were compared using Welch’s t-test and the Mann-Whitney U-test. Results: Histopathological confirmation was available in 12 patients; three were classified by follow-up. LN metastases were confirmed in five patients. 68Ga-FAPI-04 PET/CT achieved a sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of 100%. CT achieved a sensitivity and NPV of 100% but produced false-positive findings in three patients (specificity=70%, PPV=62.5%, accuracy=80%), caused by tattoo-associated lymphadenopathy, sarcoidosis and reactive nodal enlargement, none of which showed pathological tracer uptake. Metastatic LNs exhibited higher SUVmax (mean 23.2±6.0) than nodes false-positive on CT (mean 4.5±4.6; p=0.004 and p=0.036). Primary tumors were visualized in all patients undergoing initial staging; peritoneal nodules down to 7 mm were detected. Conclusion: In this small cohort, 68Ga-FAPI-04 PET/CT showed a higher observed specificity than contrast-enhanced CT for the detection of locoregional LN metastases in gynecologic SCC, with no false-negative cases observed.

View source

Similar papers

Open access Oct 2026

The role of 18F-FDG PET/CT parameters in differentiating primary lung cancer from solitary lung metastasis in patients with colorectal cancer

Distant metastasis is the leading cause of death after curative resection for colorectal cancer (CRC). Accurately distinguishing primary lung cancer (PLC) from solitary lung metastasis (SLM) in patients with solitary pulmonary nodules (SPNs) remains clinically challenging due to the limitations of biopsy and conv...

Na Wang, Huan-Xin Zhu, Yu-Nuan Liu et al. · 0 citations
Oct 2026

Prognostic Value of 68Ga-NOTA-AE105 uPAR PET/CT in Resected Non-Small Cell Lung Cancer: A Single-Center Prospective Study.

It is suggested that uPAR PET captures invasion-related tumor biology that is not fully reflected by glucose metabolism imaging that is not fully reflected by glucose metabolism imaging in non-small cell lung cancer.

P. Soldath, M. Clausen, Annika Loft et al. · 0 citations
Open access Oct 2026

Al18F-NOTA-FAPI-04 PET/CT vs. 18F-FDG in gastric adenocarcinoma: findings from a preliminary prospective comparative study

To conduct a head-to-head comparison of the clinical value of Al 18 F-NOTA-FAPI-04 PET/CT and 18 F-FDG PET/CT in the diagnosis of gastric adenocarcinoma. Fourteen patients with gastric cancer who underwent diagnosis and treatment at the Affiliated Hospital of North Sichuan Medical College between J...

Xiao-Hong Huang, Su-Ping Li, O. Ibrahim · 0 citations
Open access Oct 2026

Early Dynamic 18F-FDG PET/CT SUVmax and Its Association with Pathological Stage and Tumor Grade in Bladder Cancer: A Prospective Exploratory Study

Early dynamic 18F-FDG PET/CT imaging at 0–2 min showed the highest, although modest, diagnostic performance among the evaluated time points for predicting tumor grade and muscle invasion.

B. Saylam, Berfin Temelli, Ali Nebi̇oğlu et al. · 0 citations
Open access Oct 2026

[18F]fluorodeoxyglucose PET/CT refines staging and treatment selection in high-risk upper tract urothelial carcinoma.

OBJECTIVES To evaluate the incremental clinical value of [18F]fluorodeoxyglucose positron emission tomography/computed tomography ([18F]FDG-PET/CT) beyond contrast-enhanced computed tomography (CECT) for primary staging of suspected high-risk upper tract urothelial carcinoma (UTUC). PATIENTS AND METHODS We conducted...

R. A. G. Lijnen, J. Ringia, K. Hendricksen et al. · 0 citations
Review Open access Oct 2026

Diagnostic performance of FAPI PET/CT for detecting peritoneal metastasis in gastric cancer: an exploratory prospective study and systematic review with meta-analysis

Large-scale, well-designed prospective studies are needed to validate the diagnostic performance and clinical utility of FAPI PET/CT for detecting PM in gastric cancer and the wide confidence intervals surrounding the prospective estimates warrant cautious interpretation.

Qi-Peng Yuan, Zhen-Yu Ma, Zi-Niu Tang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.